MOLECULAR ANALYSIS OF POLIOVIRUS NEURTRALIZING EPITOPES
脊髓灰质炎病毒中和表位的分子分析
基本信息
- 批准号:2837385
- 负责人:
- 金额:$ 17.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-12-01 至 2000-11-30
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyte cell population study cellular immunity cytotoxic T lymphocyte genetically modified animals helper T lymphocyte host organism interaction human subject humoral immunity laboratory mouse laboratory rat molecular pathology monoclonal antibody mutant passive immunization poliomyelitis vaccine poliovirus protein sequence protein structure tissue /cell culture virus antigen
项目摘要
The success of the poliovirus vaccines have strongly influenced current
concepts about how vaccines work. These concepts in turn have formed the
present underlying theoretical framework for many of the strategies in
vaccine development and vaccine efficacy assessment. However, these
concepts were developed prior to our knowledge of cell-mediated immune
(CMI) responses and little direct information exists that explains the
mechanisms by which an individual's immune responses protects against
disease development. Clearly, elucidation of poliovirus-specific humoral
and CMI responses is critical to an understanding of how these responses
protect the host against disease. To achieve these goals, the specific
aims are the following:
l. The "anatomy" of the immune response will be characterized by
determining whether T helper and cytotoxic epitopes colocalize to
previously determined poliovirus neutralizing antigenic sites and by
characterizing the nature of the virus-specific T lymphocyte population.
These studies will examine whether T epitope selection is influenced by
the sequence environment and whether identification of neutralizing
antigenic sites will provide general criteria for identifying T epitope
rich regions. In addition, the subtypes of T lymphocyte populations
present in the induced response will be determined. Similar studies will
be performed in poliovirus-permissive transgenic mice (TgPVR) after viral
infection. The results will be compared with that observed in normal
C57BL/6 mice to determine whether immune responses are identical in
susceptible vs. nonsusceptible hosts.
2. The in vivo roles of the humoral and CMI responses in disease
production and/or host protection will be defined using bulk poliovirus
specific T cell populations, T cell clones of defined specificities, and
monoclonal antibodies of defined specificities. Adoptive transfer and
passive immunization studies will be performed in experimentally infected
poliovirus permissive transgenic mice. These studies will examine the
relative roles of T and B lymphocytes in virus clearance, virus spread and
pathology and ultimately host protection.
Characterization of the immune response induced upon viral infection or
vaccination is necessary to understanding the molecular basis of disease.
Although the humoral response induced by poliovirus has been extensively
studied by this and other laboratories, the cell-mediated immune response
(CMI) has remained relatively uncharacterized. The aim of the proposed
research is to develop a more detailed molecular description of the
poliovirus-specific CMI response and to study the in vivo role of the CMI
and humoral responses in disease protection.
脊髓灰质炎病毒疫苗的成功极大地影响了当前
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Characterization of the ion channels formed by poliovirus in planar lipid membranes.
脊髓灰质炎病毒在平面脂质膜中形成的离子通道的表征。
- DOI:10.1128/jvi.71.1.507-511.1997
- 发表时间:1997
- 期刊:
- 影响因子:5.4
- 作者:Tosteson,MT;Chow,M
- 通讯作者:Chow,M
The discovery and preliminary characterization of a novel trypanosomatid parasite from Rattus norvegicus and stray dogs from Alexandria, Egypt.
一种来自褐家鼠和来自埃及亚历山大的流浪狗的新型锥虫寄生虫的发现和初步表征。
- DOI:10.1080/00034983.1988.11812273
- 发表时间:1988
- 期刊:
- 影响因子:0
- 作者:Morsy,TA;Schnur,LF;Feinsod,FM;Michael,SA;Saah,A;Salama,MM;Wahba,MM
- 通讯作者:Wahba,MM
Poliovirus 2C region functions during encapsidation of viral RNA.
脊髓灰质炎病毒 2C 区在病毒 RNA 衣壳化过程中发挥作用。
- DOI:10.1128/jvi.71.11.8759-8765.1997
- 发表时间:1997
- 期刊:
- 影响因子:5.4
- 作者:Vance,LM;Moscufo,N;Chow,M;Heinz,BA
- 通讯作者:Heinz,BA
Is the 135S poliovirus particle an intermediate during cell entry?
- DOI:10.1128/jvi.74.18.8757-8761.2000
- 发表时间:2000-09-01
- 期刊:
- 影响因子:5.4
- 作者:Huang, Y;Hogle, JM;Chow, M
- 通讯作者:Chow, M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marie Chow其他文献
Marie Chow的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marie Chow', 18)}}的其他基金
EARLY STAGES OF INFECTION BY NONENVELOPED VIRUSES
无包膜病毒感染的早期阶段
- 批准号:
2700126 - 财政年份:1998
- 资助金额:
$ 17.55万 - 项目类别:
EARLY STAGES OF INFECTION BY NONENVELOPED VIRUSES
无包膜病毒感染的早期阶段
- 批准号:
6373771 - 财政年份:1998
- 资助金额:
$ 17.55万 - 项目类别:
EARLY STAGES OF INFECTION BY NONENVELOPED VIRUSES
无包膜病毒感染的早期阶段
- 批准号:
6170927 - 财政年份:1998
- 资助金额:
$ 17.55万 - 项目类别:
EARLY STAGES OF INFECTION BY NONENVELOPED VIRUSES
无包膜病毒感染的早期阶段
- 批准号:
6534097 - 财政年份:1998
- 资助金额:
$ 17.55万 - 项目类别:
EARLY STAGES OF INFECTION BY NONENVELOPED VIRUSES
无包膜病毒感染的早期阶段
- 批准号:
2887664 - 财政年份:1998
- 资助金额:
$ 17.55万 - 项目类别:
MOLECULAR ANALYSIS OF POLIOVIRUS NEURTRALIZING EPITOPES
脊髓灰质炎病毒中和表位的分子分析
- 批准号:
2061911 - 财政年份:1994
- 资助金额:
$ 17.55万 - 项目类别:
MOLECULAR ANALYSIS OF POLIOVIRUS NEURTRALIZING EPITOPES
脊髓灰质炎病毒中和表位的分子分析
- 批准号:
2061910 - 财政年份:1994
- 资助金额:
$ 17.55万 - 项目类别:
MOLECULAR ANALYSIS OF POLIOVIRUS NEURTRALIZING EPITOPES
脊髓灰质炎病毒中和表位的分子分析
- 批准号:
2003352 - 财政年份:1994
- 资助金额:
$ 17.55万 - 项目类别:
MOLECULAR ANALYSIS OF POLIOVIRUS NEURTRALIZING EPITOPES
脊髓灰质炎病毒中和表位的分子分析
- 批准号:
2607753 - 财政年份:1994
- 资助金额:
$ 17.55万 - 项目类别:
IMMUNE ENHANCEMENT OF POLIOVIRUS ANTIGENICITY
脊髓灰质炎病毒抗原性的免疫增强
- 批准号:
3546705 - 财政年份:1987
- 资助金额:
$ 17.55万 - 项目类别: